Single-dose injectable nanovaccine-in-hydrogel for robust cancer immunotherapy - My Best Medicine
My Best Medicine,
The present variants of cancer immunotherapy such as immune checkpoint blockades only benefit a small subset of patients due to…
Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy
Overview of attention for article published in Advanced Science, June 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (87th percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Readers on
- mendeley
- 30 Mendeley
